Keratinocyte Growth Factor- Hair Serum for the Prevention of Chemotherapy Induced Alopecia

NCT04554732 EARLY_PHASE1 COMPLETED

Primary aim is to provide a preliminary assessment of the efficacy of the investigational topical formula, KGF-HS, as a prophylactic treatment for chemotherapy induced alopecia. Hypothesis: KGF-HS will result in less than 50% hair loss by the end of 4 cycles of chemotherapy. The investigators will evaluate hair loss using the CTCAE (Common Terminology Criteria for Adverse Events) v4.0 alopecia grading scale.

Details

Lead sponsor	University of Arizona
Phase	EARLY_PHASE1
Status	COMPLETED
Enrolment	28
Start date	Mon Apr 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Jun 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Alopecia
• Chemotherapy-Induced Change
• Hair Loss
• Alopecia Drugs

Interventions

• Keratinocyte growth factor

Countries

United States